Functional transcranial doppler: Presymptomatic changes in fabry disease

European Neurology

Volumn 67, Issue 6, 2012, Pages 331-337

  Azevedo, Elsa ^a   Mendes, Amélia ^a   Seixas, Daniela ^b,c   Santos, Rosa ^a   Castro, Pedro ^a   Ayres Basto, Margarida ^d   Rosengarten, Bernhard ^e   Oliveira, João Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Hospital Vila Nova de Gaia/Espinho   (Portugal)

^c University of Porto   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cerebral blood flow; Cerebrovascular disease; Cerebrovascular ultrasound; Fabry disease; Magnetic resonance angiography; Magnetic resonance imaging; Neurovascular coupling; Transcranial Doppler

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; BRAIN SIZE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOGRAPHY; FABRY DISEASE; FAMILIAL DISEASE; FEMALE; GRAY MATTER; HETEROZYGOSITY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHENOTYPE; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; SYSTOLE; VISUAL CORTEX; WHITE MATTER;

ADULT; AGED; ALPHA-GALACTOSIDASE; BRAIN; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FABRY DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; POSTERIOR CEREBRAL ARTERY; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; YOUNG ADULT;

EID: 84860855551     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000337906     Document Type: Article

References (35)

1. Rombach SM, Twickler TB, Aerts JM, Linthorst GE, Wijburg FA, Hollak CE: Vasculopathy in patients with Fabry disease: Current controversies and research directions. Mol Gen Metab 2010; 99: 99-108.
2. Sims K, Politei J, Banikazemi M, Lee P: Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: Natural history data from the Fabry registry. Stroke 2009; 40: 788-794.
3. Fellgiebel A, Muller MJ, Ginsberg L: CNS manifestations of Fabry's disease. Lancet Neurol 2006; 5: 791-795. (Pubitemid 44205515)
4. Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Lohr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R: Prevalence of Fabry disease in patients with cryptogenic stroke: A prospective study. Lancet 2005; 366: 1794-1796. (Pubitemid 41642643)
5. Barbey F, Brakch N, Linhart A, Jeanrenaud X, Palecek T, Bultas J, Burnier M, Hayoz D: Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 2006; 95: 63-68. (Pubitemid 43739098)
6. Moore DF, Altarescu G, Ling GS, Jeffries N, Frei KP, Weibel T, Charria-Ortiz G, Ferri R, Arai AE, Brady RO, Schiffmann R: Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 2002; 33: 525-531. (Pubitemid 34123400)
7. Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H: Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol 2004; 251: 564-570. (Pubitemid 38680299)
8. Burlina AP, Manara R, Caillaud C, Laissy JP, Severino M, Klein I, Burlina A, Lidove O: The pulvinar sign: Frequency and clinical correlations in Fabry disease. J Neurol 2008; 255: 738-744.
9. Albrecht J, Dellani PR, Muller MJ, Schermuly I, Beck M, Stoeter P, Gerhard A, Fellgiebel A: Voxel-based analyses of diffusion tensor imaging in Fabry disease. J Neurol Neurosurg Psychiatry 2007; 78: 964-969. (Pubitemid 47310833)
10. Fellgiebel A, Keller I, Marin D, Muller MJ, Schermuly I, Yakushev I, Albrecht J, Bellhauser H, Kinateder M, Beck M, Stoeter P: Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 2009; 72: 63-68.
11. Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR: Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement. Genet Med 2006; 8: 539-548. (Pubitemid 44402030)
12. Schiffmann R: Fabry disease. Pharmacol Ther 2009; 122: 65-77.
13. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR: Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338-346. (Pubitemid 36205932)
14. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M: Mannheim Carotid Intima-Media Thickness Consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim 2004 and Brussels 2006. Cerebrovasc Dis 2007; 23: 75-80.
15. Rosset A, Spadola L, Ratib O: Osiri X: An open-source software for navigating in multidimensional DICOM images. J Digit Imaging 2004; 17: 205-216. (Pubitemid 40378992)
16. Smith SM, De Stefano N, Jenkinson M, Matthews PM: Normalized accurate measurement of longitudinal brain change. J Comp Assist Tomogr 2001; 25: 466-475. (Pubitemid 32440803)
17. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-489.
18. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS: A voxelbased morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36. (Pubitemid 32552740)
19. Azevedo E, Santos R, Freitas J, Rosas MJ, Gago M, Garrett C, Rosengarten B: Deep brain stimulation does not change neurovascular coupling in non-motor visual cortex: An autonomic and visual evoked blood flow velocity response study. Parkinsonism Relat Disord 2010; 16: 600-603.
20. Rosengarten B, Huwendiek O, Kaps M: Neurovascular coupling in terms of a control system: Validation of a second-order linear system model. Ultrasound Med Biol 2001; 27: 631-635. (Pubitemid 32492880)
21. Rosengarten B, Aldinger C, Kaufmann A, Kaps M: Comparison of visually evoked peak systolic and end diastolic blood flow velocity using a control system approach. Ultrasound Med Biol 2001; 27: 1499-1503. (Pubitemid 34028106)
22. Rosengarten B, Budden C, Osthaus S, Kaps M: Effect of heart rate on regulative features of the cortical activity-flow coupling. Cerebrovasc Dis 2003; 16: 47-52. (Pubitemid 36676996)
23. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351-356. (Pubitemid 17104996)
24. Rosengarten B, Aldinger C, Spiller A, Kaps M: Neurovascular coupling remains unaffected during normal aging. J Neuroimaging 2003; 13: 43-47. (Pubitemid 36026200)
25. Hao Q, Wong LK, Lin WH, Leung TW, Kaps M, Rosengarten B: Ethnic influences on neurovascular coupling: A pilot study in Whites and Asians. Stroke 2010; 41: 383-384.
26. Rosengarten B, Grebe M, Muller A, Voss RK, Kaps M: Severity of coronary artery disease but not degree of coronary stenosis is correlated to cerebrovascular reactivity. Cerebrovasc Dis 2009; 28: 290-297.
27. Buerk DG, Ances BM, Greenberg JH, Detre JA: Temporal dynamics of brain tissue nitric oxide during functional forepaw stimulation in rats. Neuroimage 2003; 18: 1-9. (Pubitemid 36062743)
28. Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, Pease-Fye M, Ferri R, Brady RO, Herscovitch P, Schiffmann R: Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: Reversal by enzyme replacement therapy. Circulation 2001; 104: 1506-1512. (Pubitemid 32917343)
29. Rosengarten B, Dost A, Kaufmann A, Gortner L, Kaps M: Impaired cerebrovascular reactivity in type 1 diabetic children. Diabetes Care 2002; 25: 408-410.
30. Rosengarten B, Sperner J, Gorgen-Pauly U, Kaps M: Cerebrovascular reactivity in adolescents with migraine and tension-type headache during headache-free interval and attack. Headache 2003; 43: 458-463. (Pubitemid 36554659)
31. Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M: Activation-flow coupling differentiates between vascular and Alzheimer type of dementia. J Neurol Sci 2007; 257: 149-154. (Pubitemid 46856507)
32. Azevedo E, Castro P, Santos R, Freitas J, Coelho T, Rosengarten B, Panerai R: Autonomic dysfunction affects cerebral neurovascular coupling. Clin Auton Res 2011; 21: 395-403.
33. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R: Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998; 50: 1746-1749. (Pubitemid 28283245)
34. Moore DF, Ye F, Schiffmann R, Butman JA: Increased signal intensity in the pulvinar on T 1 -weighted images: A pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 2003; 24: 1096-1101. (Pubitemid 36734228)
35. Fellgiebel A, Keller I, Martus P, Ropele S, Yakushev I, Bottcher T, Fazekas F, Rolfs A: Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients. Cerebrovasc Dis 2011; 31: 294-299.